Skip to content

A Longitudinal Cohort Study on the Changes of Physiological Mechanisms in Children After Biliary Tract Reconstruction

A Longitudinal Cohort Study on the Changes of Physiological Mechanisms in Children After Biliary Tract Reconstruction

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07530354
Enrollment
100
Registered
2026-04-15
Start date
2025-05-01
Completion date
2035-04-30
Last updated
2026-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Choledochal Cyst

Keywords

Choledochal Cyst, Cholecystectomy, Cohort Studies, Treatment Outcome, Surgical Procedures

Brief summary

Through observational studies, the long-term changes in liver function, metabolic state, immune response and other aspects of children after biliary tract reconstruction during their growth process were systematically explored. The risks of these long-term physiological changes on chronic diseases such as cardiovascular diseases, diabetic diseases and liver cirrhosis in adulthood, as well as their impacts on cognitive function, musculoskeletal health and other aspects were evaluated. How do early physiological changes affect a patient's long-term health? Are there any potential biomarkers that can predict future health outcomes? Based on the research results, preventive and intervention measures that are helpful in reducing the risk of long-term complications are proposed.

Interventions

None listed

Sponsors

Wuhan Children's Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 16 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy children matched by age and gender were selected as the control group

Exclusion criteria

* Combined with other serious diseases (such as cancer, autoimmune diseases), having obvious liver function abnormalities before surgery or being undergoing other major treatments.

Design outcomes

Primary

MeasureTime frameDescription
Targeted metabolic component detection of fecesBaseline (pre-operative); 1 week, 1 month, 3 months, 6 months, 1 year, 2 years, 3 years post-operativeMetabolite concentration in feces measured by targeted metabolomics
Detection of targeted metabolic components in plasmaBaseline (pre-operative); 1 week, 1 month, 3 months, 6 months, 1 year, 2 years, 3 years post-operativeMetabolite concentration in plasma measured by targeted metabolomics

Secondary

MeasureTime frameDescription
Fecal metagenomic sequencingBaseline (pre-operative); 1 week, 1 month, 3 months, 6 months, 1 year, 2 years, 3 years post-operativeGut microbial composition and functional genes assessed by fecal metagenomic sequencing

Countries

China

Contacts

CONTACTXueqiang Yan
yanxueqiang1@163.com+8615871716704
CONTACTJing Zhang
zhanjing010308@163.com+8613396086020

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 16, 2026